Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$5.25
-0.9%
$5.09
$2.32
$6.19
$1.02B2.01302,705 shs276,235 shs
CRH Medical Corporation stock logo
CRHM
CRH Medical
$3.99
$3.99
$1.66
$4.01
$285.76MN/A1.04 million shs388,486 shs
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$28.05
+0.7%
$26.46
$21.18
$37.13
$966.86M1.56222,928 shs91,973 shs
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$13.97
+3.5%
$13.07
$9.90
$27.20
$1.14B0.571.19 million shs593,410 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-2.75%-3.46%+18.57%+21.00%+90.65%
CRH Medical Corporation stock logo
CRHM
CRH Medical
0.00%0.00%0.00%0.00%0.00%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
-1.73%-2.69%+9.04%+9.08%+16.33%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-3.09%-1.17%-0.22%-11.71%+10.75%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
0.6802 of 5 stars
1.02.00.00.03.32.50.0
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
3.3921 of 5 stars
3.33.00.00.02.92.51.9
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1.8797 of 5 stars
4.50.00.00.03.10.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
2.00
Hold$5.13-2.38% Downside
CRH Medical Corporation stock logo
CRHM
CRH Medical
0.00
N/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.60
Moderate Buy$35.6026.92% Upside
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
2.91
Moderate Buy$36.70162.71% Upside

Current Analyst Ratings Breakdown

Latest CRHM, VRDN, AVAH, and PNTG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$36.00 ➝ $36.00
5/12/2025
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$28.00 ➝ $32.00
5/9/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$4.50 ➝ $5.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$31.00 ➝ $27.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$46.00 ➝ $45.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$42.00 ➝ $38.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$38.00 ➝ $36.00
4/23/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$34.00 ➝ $34.00
4/11/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$6.00 ➝ $5.50
4/2/2025
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$38.00 ➝ $38.00
3/14/2025
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$3.20 ➝ $4.50
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$2.09B0.49$0.72 per share7.34($0.68) per share-7.72
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$748.17M1.29$0.85 per share32.92$4.86 per share5.77
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$302K3,774.31N/AN/A$4.48 per share3.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-$134.52M$0.02N/AN/A-3.32%N/A-0.89%8/14/2025 (Estimated)
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/A0.00N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$13.38M$0.7641.2531.882.243.24%13.47%3.81%8/5/2025 (Estimated)
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$237.73M-$3.85N/AN/AN/A-85,127.16%-70.12%-41.49%8/14/2025 (Estimated)

Latest CRHM, VRDN, AVAH, and PNTG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$0.95-$0.87+$0.08-$0.87$0.16 million$0.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/AN/AN/AN/AN/A
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
N/AN/AN/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/A
0.94
0.94
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
0.58
1.12
1.12
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.04
18.55
18.55

Institutional Ownership

CompanyInstitutional Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
87.96%
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
85.88%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/A

Insider Ownership

CompanyInsider Ownership
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
7.80%
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5.40%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1.58%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
33,000195.09 million178.15 millionOptionable
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A71.62 millionN/ANot Optionable
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5,34034.47 million32.36 millionOptionable
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5081.59 million78.70 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aveanna Healthcare stock logo

Aveanna Healthcare NASDAQ:AVAH

$5.25 -0.05 (-0.94%)
Closing price 04:00 PM Eastern
Extended Trading
$5.24 0.00 (-0.10%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

The Pennant Group stock logo

The Pennant Group NASDAQ:PNTG

$28.05 +0.19 (+0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$28.06 +0.00 (+0.02%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Viridian Therapeutics stock logo

Viridian Therapeutics NASDAQ:VRDN

$13.97 +0.47 (+3.48%)
Closing price 04:00 PM Eastern
Extended Trading
$14.38 +0.40 (+2.90%)
As of 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.